Full Press Release Details
Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
| Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operations | ||
| Integrated platform accelerates pharmaceutical access, fulfillment, and commercialization | ||
| Combined ecosystem provides potential reach to an estimated 200,000+ patient lives across pharmaceutical and provider networks |
FL / ACCESS Newswire / April 14, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"),
a leading healthcare technology and pharmaceutical distribution
company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare
Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and
specialty pharmaceutical programs.
execution of the joint venture formalizes the previously announced non-binding letter of intent and represents a significant milestone
in aligning both organizations' technology platforms and operational teams into a unified ecosystem designed to accelerate patient
access and improve the efficiency of pharmaceutical commercialization. By integrating the Wellgistics Hub technology stack including
proprietary platforms EinsteinRx and HubRx AI with KareRx's digital hub, the combined platform is positioned to streamline
the prescription journey from intake through fulfillment.
Patel, Chief Executive Officer of Wellgistics Health, commented, "This joint venture reflects our continued focus on building an
integrated, technology-enabled platform to improve coordination across the prescription journey and support patient access to therapies.
By combining KareRx's provider connectivity and digital engagement capabilities with our infrastructure, we believe this collaboration
enhances operational efficiency and supports manufacturers and other healthcare stakeholders in navigating access pathways more effectively."
joint venture aligns clinical, operational, and commercial teams across both organizations, enabling more seamless coordination between
providers, pharmacies, and patients. Through this integration, the platform enhances key capabilities including eligibility and benefits
verification, prior authorization workflows, prescription routing, and direct-to-patient fulfillment. The combined ecosystem includes
a growing national footprint of independent pharmacies, provider networks, and telehealth channels, with the ability to reach more than
200,000 patient lives based on third-party internal estimates.
Panera, Founder and Chief Executive Officer of KareRx, added, "KareRx was developed to connect providers, pharmacies, and patients
through technology-driven solutions. This joint venture allows us to extend those capabilities by leveraging Wellgistics' technology
stack, pharma expertise, and operational infrastructure. We believe the combined platform will support improved connectivity across stakeholders
and facilitate access to therapies across participating networks."
collaboration further strengthens direct-to-patient (DTP) and decentralized care models, providing pharmaceutical manufacturers with
a comprehensive platform that integrates access, affordability, and fulfillment into a single solution. Leveraging AI-driven insights
and a fully integrated operational backbone, the joint venture is designed to reduce barriers to therapy initiation, improve adherence,
and deliver enhanced visibility into patient access and program performance.
joint venture remains subject to customary implementation steps, and there can be no assurance regarding the timing or extent of operational
integration or the realization of anticipated benefits. Additional details regarding the joint venture agreement will be provided in
a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission.
Wellgistics Health, Inc.
Health (NASDAQ:WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence
platform EinsteinRx into its patented blockchain-enabled smart contracts platform PharmacyChain to optimize the prescription
drug dispensing journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+
manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services
such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics
provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent
Rx Hub is an artificial intelligence (AI)-based digital hub for retail pharmacies, telemedicine portal, and specialty pharmaceutical
lite' branded products with over 500 physician-provider relationships, 200 independent pharmacy relationships that market
unique specialty pharmaceutical lite' products. Kare Rx Hub is owned by Kare Pharmtech, LLC, a company controlled by Dr.
Kiran Patel. Dr. Patel founded Medicaid provider WellCare in 1992 and sold it in 2002 for $200 million. In 2007, Dr. Patel founded America's
1st Choice Holdings and acquired Freedom Health and Optimum Holdings. In 2017, he sold America's 1st Choice Holdings to Anthem,
Inc. Dr. Patel is a noted philanthropist and was named Floridian of the Year by Florida Trend Magazine.
press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical
facts. When Wellgistics Health uses words such as "may," "will," "intend," "should,"
"believe," "expect," "anticipate," "project," "estimate," or similar expressions
that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without
limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans.
Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results
to differ materially. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.